Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	676	442	394	490	393	475
Market Cap Growth	60.16%	12.05%	-19.52%	24.78%	-17.40%	21.19%
Enterprise Value	646	485	471	571	447	548
Last Close Price	54.97	36.45	33.42	41.15	33.38	44.00
PE Ratio	10.14	6.46	40.47	44.94	-	-
PS Ratio	3.12	2.40	2.68	3.69	3.27	4.50
PB Ratio	7.14	6.19	-42.28	-26.35	-8.27	-5.63
P/TBV Ratio	7.16	6.22	-	-	-	-
P/FCF Ratio	9.45	6.90	31.48	139.32	-	-
P/OCF Ratio	9.27	6.74	29.69	77.36	-	-
EV/Sales Ratio	2.88	2.64	3.20	4.31	3.72	5.19
EV/EBITDA Ratio	8.48	8.72	21.78	29.31	154.82	-
EV/EBIT Ratio	8.88	8.93	23.05	30.58	183.33	-
EV/FCF Ratio	9.03	7.58	37.59	162.43	-	-
Debt / Equity Ratio	0.94	1.38	-12.86	-9.03	-3.74	-2.37
Debt / EBITDA Ratio	1.21	1.71	5.05	7.76	41.61	-
Debt / FCF Ratio	1.24	1.54	9.57	47.76	-	-
Net Debt / Equity Ratio	-0.31	-0.11	-6.86	-4.95	-1.20	-0.79
Net Debt / EBITDA Ratio	-0.40	-0.14	2.96	4.72	19.72	-3.96
Net Debt / FCF Ratio	-0.40	-0.12	5.11	26.16	-2.15	-1.44
Asset Turnover	1.08	0.97	0.80	0.63	0.62	0.57
Inventory Turnover	4.69	3.99	4.13	4.18	5.33	6.11
Quick Ratio	5.40	3.93	2.48	1.96	1.22	3.87
Current Ratio	6.32	4.85	3.20	2.34	1.38	4.46
Return on Equity (ROE)	121.15%	218.58%	-	-	-	-
Return on Assets (ROA)	21.88%	17.89%	6.95%	5.56%	0.79%	-5.93%
Return on Invested Capital (ROIC)	106.97%	94.46%	31.17%	44.56%	-	-
Return on Capital Employed (ROCE)	35.70%	29.10%	17.40%	14.30%	4.10%	-11.90%
Earnings Yield	9.86%	15.48%	2.47%	2.23%	-1.41%	-2.56%
FCF Yield	10.58%	14.50%	3.18%	0.72%	-6.73%	-9.74%
Buyback Yield / Dilution	-15.14%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.